Nyse fsk.

PHILADELPHIA, March 1, 2021 /PRNewswire/ -- FS KKR Capital Corp. (NYSE: FSK), a leading publicly traded business development company focused on providing customized credit solutions to private ...Dec 1, 2023 · A high-level overview of FS KKR Capital Corp (FSK) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the National Medical Products Administration (NMPA) has approved Shingrix for the prevention of shingles (herpes zoster) in adults aged 50 years or older. Shingrix is a recombinant subunit adjuvanted vaccine given intramuscularly in two doses.PHILADELPHIA, March 1, 2021 /PRNewswire/ -- FS KKR Capital Corp. (NYSE: FSK), a leading publicly traded business development company focused on providing customized credit solutions to private ...

PHILADELPHIA and NEW YORK, Nov. 8, 2021 /PRNewswire/ -- FS KKR Capital Corp. (NYSE: FSK), today reported net investment income of $201 million, or $0.71 per share for the third quarter ended ...

MenABCWY combination vaccine candidate met all its primary endpoints of the pivotal phase III clinical trial and was well tolerated with a safety profile consistent with Bexsero and Menveo. The primary endpoint data demonstrated statistical non-inferiority compared to Bexsero and Menveo in individuals 10-25 years old, with the 5-in-1 vaccine …

PHILADELPHIA, June 9, 2021 /PRNewswire/ -- FS KKR Capital Corp. (NYSE: FSK) announced that it has priced an underwritten public offering of $400,000,000 in aggregate principal amount of its 2.625% ...PHILADELPHIA, June 3, 2020 /PRNewswire/ -- FS KKR Capital Corp. (NYSE: FSK), a leading publicly traded business development company focused on providing customized credit solutions to private middle market U.S. companies, previously disclosed an investment fund with expected aggregate commitments of approximately $124 million …Both FS KKR ( NYSE: FSK) and Main Street Capital ( NYSE: MAIN) are high-yield business development companies (i.e., BDCs) with investment grade balance sheets. MAIN is internally managed and has ...FS KKR Capital (NYSE:FSK) has a trailing price-to-earnings ratio of 8.30 and a forward price-to-earnings ratio of 6.41. What is FS KKR Capital's EPS forecast for next year? FS KKR Capital's earnings are expected to decrease from $3.12 per share to $3.04 per share in the next year, which is a -2.56% change. ...Both FS KKR ( NYSE: FSK) and Main Street Capital ( NYSE: MAIN) are high-yield business development companies (i.e., BDCs) with investment grade balance sheets. MAIN is internally managed and has ...

It looks like it has potential to go green. NYSE:FSK 3/7/19 FSK is +0.31% from open, +0.63% from yesterday's close, perf week -1.85%, perf month -0.16% Change from open and yesterday's close is positive, but month and week performance are negative. But this stock passes the eye test. It looks like it has potential to go green. NYSE:FSK

The BDCs managed by FS/KKR Advisor, LLC are FS KKR Capital Corp. (NYSE: FSK) and FS KKR Capital Corp. II (NYSE: FSKR). FS Investments is a leading asset manager dedicated to helping individuals, financial professionals and institutions design better portfolios. The firm provides access to alternative sources of income and …

03 Jun, 2020, 09:00 ET. PHILADELPHIA, June 3, 2020 /PRNewswire/ -- FS KKR Capital Corp. (NYSE: FSK ), a leading publicly traded business development company focused on providing customized credit ...Tranche Update on FS KKR Capital Corp. (NYSE : FSK)‘s Equity Buyback announced on June 16, 2021. May. 24: CI Wells Fargo Adjusts Price Target on FS KKR Capital to $18.50 From $17.75, Maintains Equal-Weight Rating May. 09: MTFSK's debt-to-equity ratio is currently 1.19x and its balance sheet has plenty of flexibility, with $2.75 billion of total available liquidity (19.8% of its enterprise value).6 hari yang lalu ... Get the latest FS KKR Capital Corp. price, NYSE-FSK market cap, charts, market status & all analytical data from the world's most ...Feb 28, 2023 · FS KKR Capital Corp (NYSE:FSK) Q4 2022 Earnings Conference Call February 28, 2023 9:00 AM ETCompany Participants. Robert Paun - Director, IR. Michael Forman - Chairman & CEO. Daniel Pietrzak - Co ... Pfizer Inc. (NYSE: PFE) and GlaxoSmithKline plc (NYSE:GSK) today announced they have entered into an agreement to create a premier global consumer healthcare company with robust iconic brands. The Boards of Directors of both companies have unanimously approved the transaction under which Pfizer will contribute its …3 weeks ago. FS KKR Capital Corp. (NYSE:FSK) Q3 2023 Earnings Call Transcript. Get the latest FS KKR Capital Corp (FSK) real-time quote, historical performance, charts, and other financial ...

PHILADELPHIA, June 3, 2020 /PRNewswire/ -- FS KKR Capital Corp. (NYSE: FSK), a leading publicly traded business development company focused on providing customized credit solutions to private middle market U.S. companies, previously disclosed an investment fund with expected aggregate commitments of approximately $124 million …It's been a year since FS/KKR Advisors consolidated its funds, culminating its efforts with the FS KKR Capital Corp (NYSE:FSK) and FS KKR Capital Corp. II merger, creating the second-largest BDC .../PRNewswire/ -- FS KKR Capital Corp. (NYSE: FSK) announced that it has priced an underwritten public offering of $500,000,000 in aggregate principal amount of...Jul 10, 2022 · It's been a year since FS/KKR Advisors consolidated its funds, culminating its efforts with the FS KKR Capital Corp (NYSE: FSK) and FS KKR Capital Corp. II ( FSKR) merger, creating the second ... FS KKR Capital Corp. (NYSE:FSK) is a business development company that invests primarily in debt securities. The Philadelphia-based company invests in private middle market U.S. companies with the ...

GSK plc (LSE/NYSE: GSK) and BELLUS Health Inc. (TSX/NASDAQ: BLU) today announced GSK has completed the acquisition of BELLUS, a biopharmaceutical company working to better the lives of patients suffering from refractory chronic cough (RCC), by way of a plan of arrangement in accordance with Section 192 of the Canada …

FS KKR Capital Corp stock price (FSK) NYSE: FSK. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert FS KKR Capital Corp stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting.Form 8937 – Merger into FSK. April 2, 2021. Form 8937 – ROC (Revised) April 2, 2021. Notice to stockholders on distribution. June 15, 2020. Form 8937 – Reverse stock split. June 15, 2020. Form 8937 – Shares round u p. February 6, 2020. Form 8937 – CCT II Merger with FS KKR Capital Corp. II. February 6, 2020FS KKR Capital Stock (NYSE: FSK) stock price, news, charts, stock research, profile.FS KKR Capital Corp. (NYSE:FSK) released its earnings results on Monday, November, 6th. The company reported $0.80 EPS for the quarter, topping analysts' consensus estimates of $0.77 by $0.03. The company had revenue of $465 million for the quarter, compared to analyst estimates of $455.68 million.FS KKR Capital Corp. analyst ratings, historical stock prices, earnings estimates & actuals. FSK updated stock price target summary.It looks like it has potential to go green. NYSE:FSK 3/7/19 FSK is +0.31% from open, +0.63% from yesterday's close, perf week -1.85%, perf month -0.16% Change from open and yesterday's close is positive, but month and week performance are negative. But this stock passes the eye test. It looks like it has potential to go green. NYSE:FSKPHILADELPHIA, Jan. 10, 2022 /PRNewswire/ -- FS KKR Capital Corp. announced that it has priced an underwritten public offering of $500,000,000 in aggregate principal amount of its 3.250% unsecured...Nov 29, 2023 · FS KKR Capital Corp. (NYSE: FSK) has a higher price-to-earnings ratio of 8.30x compared to its average ratio. compared to its average ratio and a 36-month beta value of 1.39. Analysts have mixed views on the stock, with 4 analysts rating it as a “buy,” 0 as “overweight,” 7 as “hold,” and 0 as “sell.” GSK plc (LSE/NYSE: GSK) presented positive results from the pivotal EAGLE-2 and EAGLE-3 phase III trials for gepotidacin, an investigational, first-in-class oral antibiotic with a novel mechanism of action for uncomplicated urinary tract infections (uUTI) in female adults and adolescents. The data were disclosed today in an oral presentation …

FSKR’s new listing on the NYSE 48% below NAV and recent company reports hint at the company’s underappreciated value. FSKR’s and FSK’s portfolios share a similar structure and potentially ...

Overview News FS KKR Capital Corp. No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) 8.30 ( 12/01/23) EPS (TTM) $2.40 Market Cap $5.58 B Shares Outstanding 280.07 M...

FS KKR Capital ( NYSE: FSK) is a leading upper middle market business development company or BDC. As a direct lender also providing asset-based or ABL solutions, it has benefited from the ...NYSE 36.57 USD +0.58 Share price at 01 December 2023 16:00 London 1,430.78 GBp +11.38 Share price at 01 December 2023 17:39 Investors. We announced our third quarter 2023 results on Wednesday 1 November. Visit our global website for latest results. Press releases. November 13 2023 GSK and ...PHILADELPHIA and NEW YORK, Nov. 8, 2021 /PRNewswire/ -- FS KKR Capital Corp. , today reported net investment income of $201 million, or $0.71 per share for the third quarter ended September 30,... | March 15, 2023Aug 7, 2023 · PHILADELPHIA and NEW YORK, Aug. 7, 2023 /PRNewswire/ -- FS KKR Capital Corp. (NYSE: FSK), today announced its financial and operating results for the quarter ended June 30, 2023, and that its board of directors has declared a third quarter 2023 distribution totaling $0.70 per share. Emma Walmsley, the Chief Executive Officer of GSK plc (NYSE: GSK), expressed confidence in its respiratory syncytial virus (RSV) vaccine, Arexvy, anticipating sales to surpass £1 billion ($1.26 ...View live FS KKR Capital Corp. chart to track its stock's price action. Find market predictions, FSK financials and market news.WebMay 5, 2023 · FS KKR Capital Corp (NYSE:FSK) Q1 2023 Earnings Conference Call May 5, 2023 9:00 AM ETCompany Participants. Robert Paun - Director, Investor Relations. Dan Pietrzak - Co-President and Chief ... PHILADELPHIA and NEW YORK, Nov. 8, 2021 /PRNewswire/ -- FS KKR Capital Corp. (NYSE: FSK), today reported net investment income of $201 million, or $0.71 per share for the third quarter ended ...GSK plc (LSE/NYSE: GSK) today announced positive headline results from a planned interim efficacy analysis of the DREAMM-7 head-to-head phase III trial evaluating belantamab mafodotin as a second-line treatment for relapsed or refractory multiple myeloma. The trial met its primary endpoint of progression-free survival (PFS) and …Oct 10, 2023 · PHILADELPHIA and NEW YORK, Oct. 10, 2023 /PRNewswire/ -- FS KKR Capital Corp. (NYSE: FSK) announced today plans to release its third quarter 2023 results after the close of trading on the New York Stock Exchange on Monday, November 6, 2023. 3 weeks ago. FS KKR Capital Corp. (NYSE:FSK) Q3 2023 Earnings Call Transcript. Get the latest FS KKR Capital Corp (FSK) real-time quote, historical performance, charts, and other financial ...WebFSK will be the surviving entity and will continue to be managed by FS/KKR and trade on the New York Stock Exchange under the ticker symbol “FSK.” Michael Forman, Chairman and Chief Executive Officer of both FSK and FSKR, commented, “The merger of FSK and FSKR represents a significant step toward our long-term strategic goal of creating a ...

NYSE: GSK. London, United Kingdom. $36.57 +0.58 (+1.61%) Share Price. as of December 1 4:00:00 PM EST. About GSK. GlaxoSmithKline Plc is a healthcare company, which engages in the research ...PHILADELPHIA, Dec. 3, 2020 /PRNewswire/ -- FS KKR Capital Corp. (NYSE: FSK) announced that it has priced an underwritten public offering of $1,000,000 ,000 in aggregate principal amount of its 3. ...PHILADELPHIA and NEW YORK, Aug. 7, 2023 /PRNewswire/ -- FS KKR Capital Corp. (NYSE: FSK), today announced its financial and operating results for the quarter ended June 30, 2023, and that its ...FS KKR Capital Corp. (NYSE: FSK), today announced its financial and operating results for the quarter and year ended December 31, 2022, and that its board of directors has declared a first quarter ...Instagram:https://instagram. is nikola a good stock to buybody stockcyber security training market sizeshort clov Get today's stock prices, news and investor discussion about FS KKR Capital Corp (NYSE:FSK). Research FSK stock prices, stock quotes, stock trends and price ... nyse vmcaston martin crossover Why FSK Stock Is Worth Looking Into. Finding a company that pays reliable, high-yield dividends is great; finding a company that increases its payouts on a regular basis is even better. FS KKR Capital Corp (NYSE:FSK) has taken this one step better: it has been increasing its quarterly base distribution and paying special distributions. orncx FS KKR Capital Corp. (NYSE: FSK), today announced its financial and operating results for the quarter and year ended December 31, 2022, and that its board of directors has declared a first quarter ...Jul 10, 2022 · It's been a year since FS/KKR Advisors consolidated its funds, culminating its efforts with the FS KKR Capital Corp (NYSE: FSK) and FS KKR Capital Corp. II ( FSKR) merger, creating the second ... PHILADELPHIA and NEW YORK, Nov. 6, 2023 /PRNewswire/ -- FS KKR Capital Corp. (NYSE: FSK), or the Company, today announced its financial and operating results for the quarter ended September 30 ...